Tags: SOCMA Member News
SOCMA member Lonza congratulates Moderna on interim Phase 3 clinical trial data.
November 16, 2020
ChemDesign is pleased to announce the completion of its new technology center. This facility was developed and built by Keller Inc., with construction completed in the fall of 2020. The 25,000 sq. ft. facility houses multiple functional areas and will serve as the centerpiece and communication hub for the company.
November 12, 2020
Pierre-Alain Ruffieux today joins Lonza Group in the role of Chief Executive Officer. Albert Baehny has taken the role of CEO ad interim since November 2019. He will now work with Pierre-Alain to ensure a smooth handover of leadership before returning to his role as Chairman of the Board of Directors.
November 2, 2020
Lonza announced today that the company has signed
an agreement with AstraZeneca to manufacture AZD7442, a combination of two long-acting antibodies (LAABs) for the potential prevention and treatment of COVID-19.
October 30, 2020
Sun Chemical released its 11th annual Corporate Sustainability Report for the year ending 2019.
October 28, 2020
Pilot Chemical Corp., through its subsidiary Mason Chemical Company, has secured acceptance from the Environmental Protection Agency (EPA) to add a SARS-CoV-2 claim, along with four new antimicrobial claims, to the label of its Maguard® 5626 product.
October 27, 2020
LBB Specialties announced that Charkit Chemical Company has signed a domestic territory-based representation agreement with Elé Corporation, based in Chicago, Illinois.
October 27, 2020
During the 2020 Innovate Textile & Apparel virtual trade show, Sun Chemical will show how its expertise in inkjet development combined with the digital textile printing market experience from the recently acquired Sensient Imaging Technologies, will further support existing products and innovations to advance the adoption of digital printing for textiles.
October 12, 2020
Pilot Chemical Corp., a privately owned and independent global specialty chemical company, announced today that Pamela Butcher will step down from her CEO role effective January 1, 2021. She will remain on the Pilot Board of Directors and serve as a special advisor to the Chairman.
October 5, 2020
Gelest announced today it has completed the sale of Gelest Intermediate Holdings to Mitsubishi Chemical America, Inc. (MCA; Head office: New York, the United States; President: Steve Yurich), the U.S. subsidiary of Mitsubishi Chemical Corporation (MCC; Head office: Chiyoda-ku, Tokyo; President: Masayuki Waga). Gelest Intermediate Holdings is the parent of Gelest, Inc. and Bimax, Inc. (Gelest; Head office: Pennsylvania, the United States; Chair: Barry Arkles, CEO: Ken Gayer). The transaction, which was announced on April 30, 2020, has cleared all regulatory approvals.
October 5, 2020
